A Prospective Multicentric Randomized Study of Glivec in Patients With Advanced Gastrointestinal Stromal Tumors Expressing c-Kit Comparing Treatment Interruption After 5 Years vs Treatment Maintenance

Trial Profile

A Prospective Multicentric Randomized Study of Glivec in Patients With Advanced Gastrointestinal Stromal Tumors Expressing c-Kit Comparing Treatment Interruption After 5 Years vs Treatment Maintenance

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Imatinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2015 Results of a subgroup analysis published in the European Journal of Cancer
    • 21 Feb 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 25 Sep 2012 Planned End Date changed from 1 May 2017 to 1 May 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top